Trials / Unknown
UnknownNCT04766619
Process Evaluation of OptimiseRx and PINCER
Generating Recommendations for National Roll-out and Sustainable Use of Prescribing Safety Indicator Based Interventions Using Longitudinal Process Evaluation and a Consolidated Learning Exercise
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 390 (estimated)
- Sponsor
- University of Nottingham · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study aims to evaluate two interventions designed to make medication prescribing safer, OptimiseRx and PINCER, which are being used in general practices across England. The findings from the evaluation will be used to generate recommendations as to how these interventions can be used sustainably in the long-term.
Detailed description
This study has been designed to evaluate and gain an understanding of the 'real world' implementation, fidelity and medium and longer-term embedding and sustainability of two prescribing safety interventions: the computerised decision support (CDS) tool - Optimize Rx, and PINCER (pharmacist-led information technology intervention for reducing clinically important errors in medication management). The longitudinal process evaluation will involve observations, interviews, focus groups and questionnaires. The consolidated learning exercise, which aims to inform long-term, sustainable intervention use will involve a documentary analysis, interviews, focus groups, development workshops and a synthesis of the evaluation results.
Conditions
Timeline
- Start date
- 2018-02-16
- Primary completion
- 2021-08-31
- Completion
- 2023-02-28
- First posted
- 2021-02-23
- Last updated
- 2021-02-23
Locations
3 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04766619. Inclusion in this directory is not an endorsement.